Comparison between Raviraj Process Controls IPO and Speciality Medicines IPO.
Raviraj Process Controls IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Speciality Medicines IPO is a SME Bookbuilding proposed to list at BSE SME.
| Raviraj Process Controls IPO | Speciality Medicines IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Ekadrisht Capital Pvt.Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Shree Bahubali Stock Broking Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Raviraj Process Controls IPO is up to ₹0.00 Cr whereas the issue size of the Speciality Medicines IPO is up to ₹0.00 Cr. The final issue price of Raviraj Process Controls IPO is and of Speciality Medicines IPO is .
| Raviraj Process Controls IPO | Speciality Medicines IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 41,32,800 shares | 23,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 41,32,800 shares | 23,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Raviraj Process Controls IPO opens on , while Speciality Medicines IPO opens on . The closing date of Raviraj Process Controls IPO and Speciality Medicines IPO is , and , respectively.
| Raviraj Process Controls IPO | Speciality Medicines IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Raviraj Process Controls IPO P/E ratio is , as compared to Speciality Medicines IPO P/E ratio of .
| Raviraj Process Controls IPO | Speciality Medicines IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Raviraj Process Controls Limited Financial Information (Restated)
| Speciality Medicines Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 57.34 | 62.70 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 42.23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 43.94% | 40.44% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 27.10% | 34.95% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.67 | ₹7.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 43.94% | 27.36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Raviraj Process Controls IPO Retail Individual Investors (RII) are offered while in Speciality Medicines IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Raviraj Process Controls IPO and in Speciality Medicines IPO.
| Raviraj Process Controls IPO | Speciality Medicines IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Raviraj Process Controls IPO subscribed in total, whereas Speciality Medicines IPO subscribed .
| Raviraj Process Controls IPO | Speciality Medicines IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
